@article{2db86ddca741421f88ce346de9b15779,
title = "ATIM-08. TRIAL IN PROGRESS: CA209-9Y8 PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFS), NIVOLUMAB PLUS/MINUS IPILIMUMAB FOR BEVACIZUMAB-NA{\"I}VE, RECURRENT GLIOBLASTOMA",
author = "Yazmin Odia and Fabio Iwamoto",
note = "You do not currently have access to this article. Subscription prices and ordering ATIM-08. TRIAL IN PROGRESS: CA209-9Y8 PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFS), NIVOLUMAB PLUS/MINUS IPILIMUMAB FOR BEVACIZUMAB-NA{\"I}VE, RECURRENT GLIOBLASTOMA - 24 Hours access",
year = "2019",
month = nov,
day = "11",
doi = "10.1093/neuonc/noz175.008",
language = "American English",
volume = "21",
journal = "Neuro-oncology",
}